The Latest Breaking News on Pharma

Shanghai plans to build a 3,250-bed COVID-19 quarantine facility on a small island close to its city centre as China stands by its stringent zero-COVID controls, rather than relaxing curbs as many other countries have done.

The pharmacy sector is facing a difficult winter

Canberramine. Ketberra.

DALLAS — Although COVID-19 is presently at one of its lowest rates in the Lone Star State, one Texas-based vaccine scientist is wary of what’s to come this winter.

Experts fear the UK is in the middle of a fourth wave of Covid and with the winter fast approaching, an increase in respiratory illnesses is also on the horizon

Before Covid-19 vaccines were developed and distributed, China's strict approach to controlling the virus resulted in fewer deaths and a much lower death rate per million people than in many other countries. But while these successes were impressive in late 2020 and early 2021, effective vaccines and treatments have become…

Rats in Scotland are "learning to evade control measures", one pest expert has said.

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

Boston University scientists combined Omicron with the original Wuhan Covid strain to make a hybrid which killed 80% of the mice it was tested on, as experts warn such research needs better accountability